Fenistil

Poland
Brand name Fenistil
Form drops, oral solution
Active substance / Dosage
Prescription type Over-the-counter
ATC code
Registration number 100531780
Fenistil drops, oral solution

Patient Information Leaflet

Warning! Keep this leaflet! The outer packaging label is in a foreign language.
Fenistil, 1 mg/ml, oral drops, solution
Dimetinden maleate
Please read this leaflet carefully before using this medicine, as it contains important information for you.
This medicine should always be taken exactly as described in this patient leaflet or as directed by your doctor or pharmacist.

  • Keep this leaflet so that you can read it again if necessary.
  • If you need advice or further information, please consult your pharmacist.
  • If you experience any adverse reactions, including any not listed in this leaflet, inform your doctor, pharmacist, or nurse. See section 4.
  • If there is no improvement after 7 days, or if you feel worse, consult your doctor.

Table of contents:

  1. What Fenistil is and what it is used for
  2. Important information before taking Fenistil
  3. How to take Fenistil
  4. Possible side effects
  5. How to store Fenistil
  6. Contents of the pack and other information

1. What Fenistil is and what it is used for

Fenistil contains dimetinden maleate, which belongs to a group of medicines called antihistamines.
It blocks the effects of histamine, a substance in the body responsible for allergic reactions. It relieves itching and irritation caused by skin rashes, reduces swelling, and also alleviates symptoms of allergic rhinitis such as watery nasal discharge (runny nose), sneezing, nasal itching, and itchy, watery eyes.
After oral administration, the effect of the medicine begins within 30–60 minutes and lasts for 8 to 12 hours.
Fenistil is indicated for the treatment of symptoms of allergic conditions:

  • of the skin: urticaria, itching in atopic dermatitis, allergic contact dermatitis, endogenous eczema;
  • of the respiratory system: seasonal allergic rhinitis (hay fever) and perennial allergic rhinitis (e.g. allergy to house dust, animal hair, feathers). Fenistil is used for symptomatic treatment of food and drug allergies, and also relieves itching associated with infectious diseases (e.g. chickenpox). It may be used to relieve symptoms following insect bites and to prevent allergic reactions occurring during desensitization therapy. If there is no improvement after 7 days, or if you feel worse, consult your doctor.

2. Information before using Fenistil

When not to use Fenistil oral drops:

  • if the patient is allergic to dimethindene maleate or any of the other ingredients of this medicine (listed in section 6),
  • in newborns during the first month of life, especially in premature infants.

Warnings and precautions
Before starting treatment with Fenistil, discuss this with your doctor, pharmacist, or nurse.
Consult a doctor before using this medicine in patients:

  • with glaucoma,
  • urinary retention caused, for example, by benign prostatic hyperplasia,
  • epilepsy,
  • in elderly patients.

Elderly patients should contact a doctor before using this medicine, as they are more susceptible to adverse effects of this medicine, such as excitation and fatigue.
This medicine should not be used in elderly patients with disorientation.
Children and adolescents
Antihistamines may cause excitation in young children.
The use of Fenistil in infants aged 1 month to 1 year and in children under 6 years of age should be under medical supervision.
Do not exceed the recommended dose.
Keep the medicine out of sight and reach of children.
Fenistil and other medicines
Tell your doctor about all medicines currently taken or recently used, including those available without a prescription.
Do not use Fenistil without medical advice if the patient is taking any of the following medicines:

  • antidepressants,
  • anticholinergic medicines, such as: bronchodilators (medicines used in the treatment of asthma and bronchospasm), medicines used for spastic conditions in the abdominal cavity (medicines used to prevent stomach and intestinal spasms), mydriatics, urological antispasmodics (medicines used in the treatment of urinary incontinence and overactive bladder symptoms),
  • sedatives, tranquilizers,
  • anticonvulsants (medicines used in the treatment of epilepsy),
  • opioid analgesics,
  • antihistamines (medicines used in the treatment of common cough, cold, or other allergies),
  • antiemetics,
  • procarbazine (a medicine used in the treatment of certain types of cancer),
  • scopolamine (a medicine used to prevent motion sickness),
  • alcohol.

Use of Fenistil with alcohol
Like other antihistamines, Fenistil may enhance the effects of alcohol.
Pregnancy, breastfeeding and fertility
If the patient is pregnant or breastfeeding, suspects she may be pregnant, or is planning to have a child, she should consult a doctor or pharmacist before using this medicine.
Fenistil should not be used during pregnancy unless the benefits to the mother outweigh the potential risks to the fetus. The medicine may be used only under medical supervision.
Fenistil should not be used in breastfeeding women.
Driving and operating machinery
As with other antihistamines, Fenistil may impair psycho-physical performance in some patients. Therefore, individuals taking Fenistil oral drops should exercise caution when driving motor vehicles or performing other activities requiring concentration (e.g. operating machinery).
Fenistil contains benzoic acid (E 210), propylene glycol (E 1520) and sodium
The medicine contains 2 mg of benzoic acid per dose (40 drops), equivalent to 1 mg/ml.
Benzoic acid may increase the risk of jaundice (yellowing of the skin and whites of the eyes) in newborns (up to 4 weeks of age).
The medicine contains 200 mg of propylene glycol per dose (40 drops), equivalent to 100 mg/ml.
Before administering the medicine to a child under 4 weeks of age, consult a doctor or pharmacist, especially if the child is taking other medicines containing propylene glycol or alcohol.
The medicine contains less than 1 mmol (23 mg) of sodium per dose (40 drops), i.e. the medicine is considered "sodium-free".

3. How to use Fenistil

This medicine should always be taken exactly as described in this patient leaflet or as directed by a doctor, pharmacist, or nurse. If in doubt, consult a doctor, pharmacist, or nurse.
Do not exceed the recommended dose.
Use of this medicine in infants aged 1 month to 1 year and in children under 6 years of age should be under medical supervision. Do not use in children under 1 month of age.

Adults and children over 6 years of age:
Do not use this medicine for longer than 7 days.
If there is no improvement after 7 days, or if the patient's condition worsens, consult a doctor.

Adults and children over 12 years of age:
The daily dose is 3–6 mg of dimetindene, administered in 3 equal divided doses.
It is recommended to take 20 to 40 drops three times daily.
In patients prone to drowsiness, administer 40 drops at bedtime and 20 drops in the morning with breakfast.

Children under 12 years of age:
The recommended daily dose is 0.1 mg/kg body weight/day, i.e. 2 drops per kg of body weight per day, divided into 3 doses, for example:
6 drops three times daily in the case of a 9 kg, 8-month-old infant.
8 drops three times daily in the case of a 12 kg, 2-year-old child.

Do not exceed the maximum daily dose, which is as follows:
Age Maximum daily dose
1 month – 1 year 1.5 mg 30 drops
1 – 3 years 2.25 mg 45 drops
3 – 12 years 3 mg 60 drops
20 drops = 1 ml = 1 mg dimetindene

Infants aged 1 month to 1 year and children under 6 years of age:
Use in infants aged 1 month to 1 year and in children under 6 years of age should be under medical supervision.

Fenistil should not be exposed to high temperatures. If the infant is bottle-fed, add the medicine to the bottle with warm food immediately before feeding. If the infant is spoon-fed, the drops may be administered undiluted on a small teaspoon.

Elderly patients
Elderly patients should consult a doctor before using this medicine.

Overdose of Fenistil
In case of an overdose of Fenistil, seek immediate medical advice from a doctor or pharmacist.
Symptoms of overdose include: drowsiness (mainly in adults), central nervous system stimulation (mainly in children and elderly patients), including agitation, impaired motor coordination, hallucinations, tremors, convulsions, as well as urinary retention and fever. A drop in blood pressure, coma, and circulatory-respiratory collapse may also occur.

Missed dose of Fenistil
If a dose of Fenistil is missed, take it as soon as possible, provided that less than 2 hours remain until the next scheduled dose. Otherwise, take the medicine at the usual time. Do not take a double dose to make up for a missed dose.

If you have any further questions about the use of this medicine, consult your doctor or pharmacist.

4. Possible adverse reactions

Like all medicines, Fenistil may cause adverse reactions, although not everyone experiences them.
You should STOP using the medicine and contact your doctor immediately if any of the following symptoms occur, as they may be signs of an allergic reaction:

  • difficulty breathing or swallowing,
  • swelling of the face, lips, tongue or throat,
  • severe skin itching with red rash or spreading blisters, muscle cramps.

These symptoms occur very rarely (may occur in fewer than 1 in 10,000 people).
Other adverse reactions that may occur are usually mild and transient. The most common ones occur especially at the beginning of treatment.
Very common (may affect more than 1 in 10 people using the medicine): tiredness.
Common (affect fewer than 1 in 10 people using the medicine): drowsiness, nervousness.
Rare (may affect fewer than 1 in 1,000 people using the medicine): excitation, headache, dizziness, gastrointestinal disturbances, nausea, dry mouth, dry throat.
If any of the adverse symptoms worsen or if any adverse reactions not listed in this leaflet occur, inform your doctor or pharmacist.
Reporting of adverse reactions
If any adverse reactions occur, including those not listed in this leaflet, inform your doctor, pharmacist or nurse. Adverse reactions can be reported directly to the Department of Monitoring Adverse Drug Reactions of the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, phone: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting adverse reactions allows the collection of further information on the safety of medicine use.

5. How to store Fenistil

Keep this medicine out of sight and reach of children.
Store below 25°C. Keep in the original packaging to protect from light.
Do not use this medicine after the expiry date stated on the container. The expiry date refers to the last day of the stated month.
Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Contents of the package and other information

What Fenistil contains

  • The active substance is dimetindene maleate. Each millilitre of Fenistil contains 1 mg of dimetindene maleate.
  • Other ingredients are propylene glycol (E 1520), benzoic acid (E 210), disodium edetate (E 386), disodium phosphate dodecahydrate (E 339), citric acid monohydrate (E 330), sodium saccharin (E 954), purified water.

What Fenistil looks like and contents of the pack
Fenistil is a solution, clear, colourless to slightly yellowish-brown, in an amber glass bottle with a polyethylene dropper and a white polypropylene cap or a child-resistant white polypropylene cap, packed in a cardboard box.
Pack size available: 1 bottle of 20 ml.
For more detailed information, please contact the responsible party or the parallel importer.
Responsible party in Croatia, country of export:
Haleon Hungary Kft.
Csörsz u. 43
1124 Budapest
Hungary
Manufacturer:
Haleon Germany GmbH
Barthstrasse 4
80339 Munich
Germany
Parallel importer:
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
Repackaged in:
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Marketing authorisation number in Croatia, country of export: HR-H-870677704-01
Parallel import authorisation number: 30/26